¼¼°èÀÇ ECG ÆÐÄ¡ ¹× ȦÅÍ ¸ð´ÏÅÍ ½ÃÀå
ECG Patch and Holter Monitor
»óǰÄÚµå : 1786472
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 220 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,150,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,452,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ECG ÆÐÄ¡ ¹× ȦÅÍ ¸ð´ÏÅÍ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 54¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 19¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ECG ÆÐÄ¡ ¹× ȦÅÍ ¸ð´ÏÅÍ ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 19.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 54¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ECG ÆÐÄ¡´Â CAGR 17.9%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á±îÁö 34¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ȦÅÍ ¸ð´ÏÅÍ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 22.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 4¾ï 8,720¸¸ ´Þ·¯, Áß±¹Àº CAGR 18.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ECG ÆÐÄ¡ ¹× ȦÅÍ ¸ð´ÏÅÍ ½ÃÀåÀº 2024³â¿¡ 4¾ï 8,720¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 8¾ï 3,640¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 18.6%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, °¢°¢ ºÐ¼® ±â°£ µ¿¾È¿¡ 17.8%¿Í 17.2%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 14.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ECG ÆÐÄ¡ ¹× ȦÅÍ ¸ð´ÏÅÍ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿þ¾î·¯ºíÀº ½ÉÀå °Ç°­ ¸ð´ÏÅ͸µ ¹æ¹ýÀ» ÀçÁ¤ÀÇÇÒ °ÍÀΰ¡?

ECG ÆÐÄ¡¿Í ÃֽŠȦÅÍ ¸ð´ÏÅÍÀÇ µîÀåÀº ½ÉÀå Áø´ÜÀÇ Àü¸ÁÀ» À籸¼ºÇϰí ȯÀÚ¿Í ÀÓ»óÀÇ¿¡°Ô º¸´Ù È¿À²ÀûÀÌ°í ´«¿¡ Àß ¶çÁö ¾ÊÀ¸¸ç dzºÎÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© ±âÁ¸ÀÇ ½ÉÀå ¸ð´ÏÅ͸µÀ» ´ëüÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ¼ÒÇüÀÇ ºñħ½ÀÀû ÀåÄ¡´Â 24½Ã°£¿¡¼­ ¼ö ÁÖ¿¡ °ÉÃÄ Àå½Ã°£ ¿¬¼Ó ½ÉÀüµµ¸¦ ±â·ÏÇÒ ¼ö ÀÖ¾î ºÎÁ¤¸ÆÀ̳ª ½É¹æ¼¼µ¿°ú °°ÀÌ ÀÓ»ó¿¡¼­ ÈçÈ÷ ¹ß°ßµÇÁö ¾Ê´Â ½ÉÀå ÀÌ»óÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ºÎÇǰ¡ Å« À¯¼± ¸ð´ÏÅÍ¿¡¼­ °¡º­¿î ¹«¼± ECG ÆÐÄ¡·Î ÁøÈ­Çϸ鼭 ƯÈ÷ ¿Ü·¡ ¹× ÀçÅà ¸ð´ÏÅ͸µ¿¡¼­ ȯÀÚÀÇ ¼øÀÀµµ¿Í Æí¾ÈÇÔÀ» ȹ±âÀûÀ¸·Î °³¼±Çß½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº Àü ¼¼°èÀûÀ¸·Î ½ÉÇ÷°üÁúȯÀÇ Áõ°¡¸¦ °í·ÁÇÒ ¶§ ƯÈ÷ Áß¿äÇÑ Àǹ̸¦ Áö´Õ´Ï´Ù. ÇコÄÉ¾î ½Ã½ºÅÛÀÌ ÀÏȸ¼º Ä¡·á¿¡¼­ Àå±âÀûÀÎ »óÅ °ü¸®¿¡ ÃÊÁ¡À» ¸ÂÃ߸鼭 ¿þ¾î·¯ºí ECG ±â¼úÀ» ÅëÇÑ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ ³Î¸® äÅõǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, COVID-19 »çÅ·ΠÀÎÇØ ¿¹¹æÀÇ·á, Á¶±â¹ß°ß, ¿ø°ÝÁø·á°¡ °­Á¶µÇ¸é¼­ ÀÓ»óÀǰ¡ º´¿ø¿¡ ÀÚÁÖ ¹æ¹®ÇÏÁö ¾Ê°íµµ ȯÀÚ¸¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ÉÀüµµ ÆÐÄ¡ ¹× ȦÅÍ ¸ð´ÏÅÍ´Â ÇöÀç Áø´Ü ¹× Ä¡·á ÈÄ ÃßÀû ¸ñÀûÀ¸·Î »ç¿ëµÇ¾î ȯÀÚÀÇ Ä¡·á °æ·Î¸¦ °£¼ÒÈ­Çϰí, ½Ç½Ã°£ ½ÉÀå °ü·Ã ÀλçÀÌÆ®¸¦ ÅëÇØ ´õ ³ªÀº Ä¡·á °á°ú¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀº ECG ¸ð´ÏÅ͸µ ±â±âÀÇ ´É·ÂÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

±â¼ú Çõ½ÅÀ» ÅëÇØ ECG ÆÐÄ¡ ¹× ȦÅÍ ¸ð´ÏÅ͸µ ±â±âÀÇ ¼º´É, »ç¿ë ÆíÀǼº ¹× ÀÓ»óÀû Ÿ´ç¼ºÀÌ Å©°Ô Çâ»óµÇ¾î º¸´Ù Á¤È®ÇÑ Áø´Ü°ú µðÁöÅÐ ÇコÄÉ¾î »ýŰ迡 ¿øÈ°ÇÏ°Ô ÅëÇÕµÉ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÁÖ¿ä ¹ßÀü »çÇ×À¸·Î´Â ½ÅÈ£ ó¸® ¾Ë°í¸®ÁòÀÇ °³¼±, ±¸¼º¿ä¼ÒÀÇ ¼ÒÇüÈ­, Ŭ¶ó¿ìµå ±â¹Ý µ¥ÀÌÅÍ ÀúÀå, AI ±â¹Ý ºÐ¼®À¸·Î ÀÌ»ó ¡Èĸ¦ ÀÚµ¿À¸·Î °¨ÁöÇÏ¿© Ç÷¡±×¸¦ Ç¥½ÃÇÏ´Â °Í µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â ´õ ÀÌ»ó ´Ü¼øÇÑ ±â·Ï ÀåÄ¡°¡ ¾Æ´Ï¶ó ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿¡°Ô Á÷Á¢ °æ°í¸¦ º¸³¾ ¼ö ÀÖ´Â ½Ç½Ã°£ Áø´Ü µµ±¸·Î, º¸´Ù ½Å¼ÓÇÑ ÀÇ»ç°áÁ¤À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¹«¼± Åë½Å ±â´ÉÀ» °®Ãá ECG ÆÐÄ¡´Â µ¥ÀÌÅ͸¦ Áö¼ÓÀûÀ¸·Î Àǻ翡°Ô Àü¼ÛÇϰí, ¿ø°ÝÀÇ·á Ç÷§Æû ¹× ¸ð¹ÙÀÏ ¾Û°ú ÅëÇÕÇÏ¿© ½Ç½Ã°£À¸·Î Çǵå¹éÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇöÀç ÀϺΠÆÐÄ¡¿¡´Â °¡¼Óµµ°è, ü¿Â°è µî »ýü ¼¾¼­°¡ Ãß°¡µÇ¾î ECG µ¥ÀÌÅÍ¿¡ ¸Æ¶ôÀ» ºÎ¿©ÇÏ¿© Áø´Ü Á¤È®µµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃֽŠȦÅÍ ¸ð´ÏÅÍ´Â ÃæÀü½Ä ¹èÅ͸®¸¦ žÀçÇϰí, Âø¿ë ½Ã°£ÀÌ ±æ¾îÁöµµ·Ï ¼³°èµÇ¾î ȯÀÚÀÇ ÀçÁø·á Çʿ伺À» ÁÙÀÌ°í ¸ð´ÏÅ͸µ È¿À²À» ³ô¿´½À´Ï´Ù. ÀüÀڰǰ­±â·Ï(EHR)°úÀÇ »óÈ£¿î¿ë¼ºµµ °³¼±µÇ¾î ÀÓ»óÀÇ´Â ±â·ÏµÈ µ¥ÀÌÅ͸¦ ½±°Ô °Ë»ö, ºÐ¼®, ´ëóÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº Áø´Ü ½Ã°£À» ´ÜÃàÇϰí, ¿öÅ©Ç÷οì È¿À²¼ºÀ» °³¼±Çϸç, ±âÁ¸ ½ÉÀå °Ë»ç ¹æ¹ý¿¡ ´ëÇÑ º¸´Ù ȯÀÚ Ä£È­ÀûÀÎ ´ë¾ÈÀ» Á¦°øÇÔÀ¸·Î½á ÀÌ ±â¼úÀ» Ä¿³ØÆ¼µå ÄɾîÀÇ ÃÖÀü¼±¿¡ ¹èÄ¡Çϰí ÀÖ½À´Ï´Ù.

ȯÀÚµéÀÇ ±â´ë¿Í ÀÓ»ó °üÇàÀÇ º¯È­°¡ ½ÃÀå ¼ö¿ä¸¦ Çü¼ºÇϰí Àִ°¡?

°³ÀÎÈ­, ÀçÅñٹ«, µ¥ÀÌÅÍ ±â¹Ý ÀÇ·á·ÎÀÇ ÀüȯÀº ECG ÆÐÄ¡ ¹× ȦÅÍ ¸ð´ÏÅÍÀÇ Ã¤Å÷ü Áõ°¡¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿À´Ã³¯ÀÇ È¯ÀÚµéÀº ÀÓ»óÀû Á¤È®¼º»Ó¸¸ ¾Æ´Ï¶ó Æí¾ÈÇÔ, ÆíÀǼº, ¿øÈ°ÇÑ µðÁöÅÐ »óÈ£ ÀÛ¿ëÀ» ±â´ëÇÕ´Ï´Ù. À̴ ƯÈ÷ ½ÉÀå ¸ð´ÏÅ͸µ°ú °ü·ÃÀÌ ÀÖÀ¸¸ç, ½Å·ÚÇÒ ¼ö ÀÖ´Â Áø´Ü µ¥ÀÌÅ͸¦ ¾ò±â À§Çؼ­´Â »ç¿ëÀÚÀÇ ÄÄÇöóÀ̾𽺰¡ ÇʼöÀûÀÔ´Ï´Ù. ¿þ¾î·¯ºí ÆÐÄ¡´Â Á¢Âø½Ä µðÀÚÀÎÀ¸·Î ¿ÜºÎ ¸®µå¼±ÀÌ ¾ø±â ¶§¹®¿¡ °í·ÉÀÇ È¯ÀÚ³ª Àå±âÀûÀÎ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ È¯Àڵ鿡°Ô ƯÈ÷ ÀαⰡ ÀÖ½À´Ï´Ù. ÇÑÆí, ÀÇ»ç¿Í ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â Áø´Ü, À§Çè °èÃþÈ­, Ä¡·á °ü¸®, ƯÈ÷ ½É¹æ¼¼µ¿, ½Ç½Å, ¿øÀÎ ºÒ¸íÀÇ ½É°èÇ×Áø µîÀÇ Áõ»ó¿¡ ´ëÇØ µ¥ÀÌÅÍ¿¡ ±â¹ÝÇÑ ÆÇ´ÜÀ» ³»¸®±â À§ÇØ Áö¼ÓÀûÀÎ ¿Ü·¡ ½ÉÀüµµ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ½Ã½ºÅÛÀº ¶ÇÇÑ ECG ÆÐÄ¡¿Í °°Àº Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ ¸ð´ÏÅ͸µ µµ±¸¸¦ ÅëÇØ ºñ¿ëÀÌ ¸¹ÀÌ µå´Â ±Þ¼º±â ¿¡ÇǼҵå¿Í ÀçÀÔ¿øÀ» ¿¹¹æÇÒ ¼ö ÀÖ´Â °¡Ä¡ ±â¹Ý ÄÉ¾î ¸ðµ¨À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² ½º¸¶Æ®¿öÄ¡¿Í °°Àº ¼ÒºñÀÚ ¿þ¾î·¯ºí ±â±âµéÀÌ ½ÉÀå °Ç°­¿¡ ´ëÇÑ ÀνÄÀ» È®»ê½ÃŰ¸é¼­ °³ÀÎ¿ë ±â±â°¡ ³ªÅ¸³»´Â Áõ»ó¿¡ ´ëÇØ °ø½ÄÀûÀÎ Áø´Ü µµ±¸¸¦ ã´Â »ç¶÷µéÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÓ»ó ¿öÅ©Ç÷ο쵵 ÀûÀÀÇϰí ÀÖÀ¸¸ç, ¼øÈ¯±â Àü¹®ÀǵéÀº ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» ¿Ü·¡ ȯÀÚ ¼³Á¤, ¿ø°ÝÁø·á, ¸¸¼º Ä¡·á ÇÁ·Î±×·¥¿¡ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. ȯÀÚ Âü¿©°¡ ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ Àü·«Àû ÃÊÁ¡ÀÌ µÇ¸é¼­ ECG ÆÐÄ¡ ¹× ȦÅÍ ¸ð´ÏÅÍ ±â¼úÀº ÀÓ»óÀû Á¤È®¼º°ú ÀÏ»óÀûÀÎ »ç¿ë ÆíÀǼº »çÀÌÀÇ °£±ØÀ» ¸Þ¿ö ¿¬¼ÓÀûÀÎ ½ÉÀå °ü¸® Á¦°øÀ» ÀçÁ¤ÀÇÇϰí ÀÖ½À´Ï´Ù.

ECG ÆÐÄ¡ ¹× ȦÅÍ ¸ð´ÏÅÍ ½ÃÀåÀÇ ±Þ¼ºÀå ¿øµ¿·ÂÀº?

ECG ÆÐÄ¡ ¹× ȦÅÍ ¸ð´ÏÅÍ ½ÃÀåÀÇ ¼ºÀåÀº ÀÇ·á ±â¼úÀÇ ¹ßÀü, ȯÀÚ Çൿ, ÀÇ·á ¼­ºñ½º Á¦°ø ¸ðµ¨, ÀÓ»ó ¿ä±¸ »çÇ׿¡ ±â¹ÝÇÑ ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ºÎǰÀÇ ¼ÒÇüÈ­, ¹èÅ͸® ¼ö¸í ¿¬Àå, ºí·çÅõ½º ¿¬°á, AI¸¦ Ȱ¿ëÇÑ ºÎÁ¤¸Æ °¨Áö µîÀÇ ±â¼ú Çâ»óÀ¸·Î ÀÌ·¯ÇÑ ÀåÄ¡µéÀº ´õ¿í ±â´ÉÀûÀÌ°í »ç¿ëÇϱ⠽±°í »ç¿ëÀÚ Ä£È­ÀûÀ¸·Î º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÓ»óÀûÀ¸·Î´Â ½É¹æ¼¼µ¿, ¼­¸Æ, ½Ç½Å µî ½ÉÇ÷°üÁúȯÀÇ Àü ¼¼°è À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó, ƯÈ÷ °í·ÉÈ­ Àα¸¿¡¼­ º¸´Ù ±¤¹üÀ§Çϰí Àå±â°£ÀÇ ½ÉÀå ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¿ø°ÝÀÇ·á Ç÷§ÆûÀ» ÅëÇÑ ¿ø°Ý ¸ð´ÏÅ͸µ ¹× ÀçÅà Áø´ÜÀ¸·ÎÀÇ Àüȯµµ ½Ç½Ã°£ µ¥ÀÌÅÍ¿Í Á¶±â °æº¸¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÏ´Â ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅÍ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. º´¿ø, Áø·á¼Ò, ¼øÈ¯±â Ŭ¸®´ÐÀº ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀ» äÅÃÇÏ¿© ´ë¸é ÈÄ¼Ó Á¶Ä¡¸¦ ÁÙÀ̰í ÀÓ»óÀÇÀÇ ¾÷¹«·®À» ÃÖÀûÈ­Çϱâ À§ÇØ ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ÒºñÀÚ Çൿµµ º¯È­Çϰí ÀÖÀ¸¸ç, ƯÈ÷ ¿Ü·¡ ȯÀÚ ¹× ¿¹¹æ ÀÇ·á »óȲ¿¡¼­ ±âÁ¸ÀÇ È¦ÅÍ ¸ð´ÏÅ͸¦ ´ëüÇÒ ¼ö ÀÖ´Â ºñħ½ÀÀûÀÌ°í Æí¾ÈÇÑ ´ë¾ÈÀ» ã´Â ȯÀÚµéÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÁöºÒÀÚ¿Í º¸Çè»ç´Â ½É¹æ¼¼µ¿ ¹× ±âŸ ºÎÁ¤¸Æ¿¡ ´ëÇÑ Àå±â ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ÀçÁ¤Àû Áö¿øÀ» ÅëÇØ äÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Á¦¾àȸ»ç¿Í Àӻ󿬱¸±â°üµµ Áö¼ÓÀûÀÎ ½ÉÀå ¾ÈÀü¼º µ¥ÀÌÅ͸¦ ¼öÁýÇϱâ À§ÇØ ECG ÆÐÄ¡¸¦ ÀÓ»ó½ÃÇè¿¡ µµÀÔÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÃËÁø¿äÀÎÀÌ °áÇյǾî ECG ÆÐÄ¡ ¹× ȦÅÍ ¸ð´ÏÅÍ ±â¼úÀÇ °í¼ºÀå ȯ°æÀÌ Çü¼ºµÇ¾î ½ÃÀåÀº ±â¼ú Çõ½ÅÀÇ È®´ë, äÅ÷ü Çâ»ó, ÀÇ·á ¼­ºñ½º Á¦°øÀÇ ÁÖ·ù¿¡ ´ëÇÑ ÅëÇÕÀÌ ½ÉÈ­µÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(ECG ÆÐÄ¡, ȦÅÍ ¸ð´ÏÅÍ), ¿ëµµ(Áø´Ü ¿ëµµ, ¸ð´ÏÅ͸µ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø¡¤Áø·á¼Ò, ¿Ü·¡ ½Ã¼³, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°è °íÀ¯ÀÇ SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global ECG Patch and Holter Monitor Market to Reach US$5.4 Billion by 2030

The global market for ECG Patch and Holter Monitor estimated at US$1.9 Billion in the year 2024, is expected to reach US$5.4 Billion by 2030, growing at a CAGR of 19.6% over the analysis period 2024-2030. ECG Patch, one of the segments analyzed in the report, is expected to record a 17.9% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Holter Monitors segment is estimated at 22.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$487.2 Million While China is Forecast to Grow at 18.6% CAGR

The ECG Patch and Holter Monitor market in the U.S. is estimated at US$487.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$836.4 Million by the year 2030 trailing a CAGR of 18.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.8% and 17.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.

Global ECG Patch and Holter Monitor Market - Key Trends & Drivers Summarized

Are Wearables Redefining the Way Cardiac Health Is Monitored?

The emergence of ECG patches and modern Holter monitors is reshaping the cardiac diagnostics landscape, offering patients and clinicians more efficient, discreet, and data-rich alternatives to traditional cardiac monitoring. These compact, non-invasive devices allow continuous electrocardiogram recording over extended periods-ranging from 24 hours to several weeks-enabling early detection of arrhythmias, atrial fibrillation, and other heart abnormalities that often go unnoticed in clinical settings. The evolution from bulky, wire-laden monitors to lightweight, wireless ECG patches has dramatically improved patient compliance and comfort, especially for ambulatory and home-based monitoring. These developments have become especially critical given the global rise in cardiovascular disease, which remains the leading cause of mortality worldwide. As healthcare systems shift focus from episodic care to long-term condition management, continuous monitoring through wearable ECG technology has gained widespread adoption. Moreover, the increased emphasis on preventive healthcare, early detection, and remote care-amplified by the COVID-19 pandemic-has heightened demand for technologies that enable clinicians to monitor patients in real time, without requiring frequent hospital visits. ECG patches and Holter monitors now serve both diagnostic and post-treatment tracking purposes, streamlining patient care pathways and supporting better outcomes through real-time cardiac insights.

How Is Technology Elevating the Capabilities of ECG Monitoring Devices?

Technological innovation has significantly enhanced the performance, usability, and clinical relevance of ECG patch and Holter monitoring devices, enabling more accurate diagnostics and seamless integration into digital healthcare ecosystems. Key advancements include improved signal processing algorithms, miniaturization of components, cloud-based data storage, and AI-powered analytics that automatically detect and flag anomalies. These devices are no longer just recorders; they are real-time diagnostic tools capable of sending alerts directly to healthcare providers, empowering faster decision-making. With wireless communication capabilities, ECG patches can transmit data continuously to physicians, integrating with telehealth platforms and mobile apps for real-time feedback. Some patches now include additional biometric sensors, such as accelerometers and temperature monitors, which provide context for ECG data and enhance diagnostic precision. Furthermore, modern Holter monitors are designed with rechargeable batteries and extended wear times, reducing the need for repeated patient visits and increasing monitoring efficiency. Device interoperability with electronic health records (EHRs) has also improved, making it easier for clinicians to retrieve, analyze, and act on recorded data. These innovations are reducing diagnostic turnaround times, improving workflow efficiencies, and offering a more patient-friendly alternative to traditional cardiac testing modalities, positioning the technology at the forefront of connected care.

Are Changing Patient Expectations and Clinical Practices Reshaping Market Demand?

The shift toward personalized, home-based, and data-driven healthcare is playing a pivotal role in the rising adoption of ECG patches and Holter monitors. Today’s patients expect not only clinical accuracy but also comfort, convenience, and seamless digital interaction. This is particularly relevant in cardiac monitoring, where user compliance is essential to capturing reliable diagnostic data. Wearable patches, with their adhesive design and lack of external leads, have become especially popular among elderly patients and those requiring long-term monitoring. Meanwhile, physicians and healthcare providers are increasingly relying on continuous ambulatory ECG monitoring to make data-informed decisions for diagnosis, risk stratification, and therapy management-especially for conditions such as atrial fibrillation, syncope, or palpitations with uncertain origins. Healthcare systems are also embracing value-based care models, in which accurate and timely monitoring tools like ECG patches can prevent costly acute episodes and readmissions. In parallel, consumer-grade wearables like smartwatches have popularized heart health awareness, prompting more individuals to seek formal diagnostic tools for symptoms flagged by personal devices. Clinical workflows are adapting too, with cardiologists integrating remote monitoring solutions into outpatient settings, teleconsultations, and chronic care programs. As patient engagement becomes a strategic focus for providers, ECG patch and Holter monitor technologies are bridging the gap between clinical precision and everyday usability, redefining cardiac care delivery across the continuum.

What Is Powering the Rapid Growth of the ECG Patch and Holter Monitor Market?

The growth in the ECG patch and Holter monitor market is driven by several factors rooted in medical technology evolution, patient behavior, healthcare delivery models, and clinical requirements. Technological improvements-such as the miniaturization of components, longer battery life, Bluetooth-enabled connectivity, and AI-powered arrhythmia detection-have made these devices more functional, accessible, and user-friendly. On the clinical front, the rising global incidence of cardiovascular disorders like atrial fibrillation, bradycardia, and syncope has necessitated more widespread and prolonged cardiac monitoring, especially in aging populations. The shift toward remote monitoring and home-based diagnostics, supported by telehealth platforms, has also increased demand for wearable cardiac monitors that provide real-time data and early warning insights. Hospitals, clinics, and cardiology practices are adopting these solutions to reduce in-person follow-ups and optimize clinician workload. Additionally, consumer behavior is changing, with more patients seeking non-invasive, comfortable alternatives to traditional Holter monitors, particularly in outpatient or preventive care scenarios. Healthcare payers and insurance providers are further supporting adoption through favorable reimbursement for long-term monitoring in atrial fibrillation and other arrhythmias. Pharmaceutical companies and clinical research organizations are also employing ECG patches in trials to gather continuous cardiac safety data. Collectively, these drivers are shaping a high-growth environment for ECG patch and Holter monitor technologies, pushing the market toward greater innovation, higher adoption, and deeper integration into mainstream healthcare delivery.

SCOPE OF STUDY:

The report analyzes the ECG Patch and Holter Monitor market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (ECG Patch, Holter Monitors); Application (Diagnostics Application, Monitoring Application); End-Use (Hospitals & Clinics End-Use, Ambulatory Facilities End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â